v3.26.1
10-K Subsequent events (Details)
$ in Millions
Jun. 05, 2026
Feb. 23, 2026
Feb. 18, 2026
USD ($)
Mar. 31, 2026
Dec. 31, 2025
Oct. 10, 2025
Dec. 31, 2024
Subsequent events              
Subsequent Events              
Reverse stock split 0.33            
Four20 Pharma GmbH              
Subsequent Events              
Ownership interest by minority shareholders   45.00%     45.00%   45.00%
Four20 Pharma GmbH | Subsequent events              
Subsequent Events              
Ownership interest by minority shareholders   45.00%          
Percentage of ownership after transaction   100.00%          
Senior Secured Notes – 2029              
Subsequent Events              
Gross proceeds     $ 500.0        
Debt issuance costs net     8.1        
Senior Secured Notes – 2029 | Subsequent events              
Subsequent Events              
Gross proceeds     500.0        
Senior Secured Notes – 2029 | Line of credit              
Subsequent Events              
Stated interest rate       11.50%      
Senior Secured Notes – 2029 | Line of credit | Subsequent events              
Subsequent Events              
Gross proceeds     500.0        
Debt issuance costs net     $ 8.1        
Stated interest rate     11.50%        
Amended Needham LOC | Line of credit              
Subsequent Events              
Stated interest rate     8.99% 8.99% 7.99% 7.99%  
Amended Needham LOC | Line of credit | Subsequent events              
Subsequent Events              
Stated interest rate     8.99%        
Amended Needham LOC | Line of credit | Revolving credit facility | Subsequent events              
Subsequent Events              
Stated interest rate     8.99%     7.99%